EMD Serono, Inc. is a leader in the U.S. biopharmaceutical industry. They have more than 1,100 employees throughout the United States with fully integrated commercial, clinical, and research operations in Rockland, Massachusetts.
EMD Serono has more than 30 trials in our global clinical pipeline, focused on developing innovative therapies for cancer and neurodegenerative diseases such as multiple sclerosis and Parkinson’s disease. In 2008, they launched a $65 million project to expand their research operations in Billerica, Massachusetts. This new center of excellence, which opened in early 2011, brings together the expertise of more than 250 scientists and employees committed to discovering and developing new therapies for cancer, neurodegenerative diseases and infertility.
EMD Serono is committed to transforming science into breakthrough medicine and solutions of the highest quality to make a real difference in the lives of patients and their caregivers. They are dedicated to the task of understanding diseases and developing the treatments of the future. To achieve this mission, they invest heavily in research and development as they build on their current therapeutic areas and move into new disease areas.
To learn more about EMD Serono, see their website at www.emdserono.com
Address: 45A Middlesex Turnpike Billerica, MA 01821Visit Website